The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention - PubMed (original) (raw)
. 1996 Jan 17;275(3):210-6.
T J Dondero, M A Rayfield, J R George, G Schochetman, H W Jaffe, C C Luo, M L Kalish, B G Weniger, C P Pau, C A Schable, J W Curran
Affiliations
- PMID: 8604174
The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention
D J Hu et al. JAMA. 1996.
Abstract
The discovery of highly divergent strains of human immunodeficiency virus (HIV) not reliably detected by a number of commonly used diagnostic tests has underscored the need for effective surveillance to track HIV variants and to direct research and prevention activities. Pathogens such as HIV that mutate extensively present significant challenges to effective monitoring of pathogens and to disease control. To date, relatively few systematic large-scale attempts have been made to characterize and sequence HIV isolates. For most of the world, including the United States, information on the distribution of HIV strains among different population groups is limited. We describe herein the implications resulting from the rapid evolution of HIV and the need for systematic surveillance integrated with laboratory science and applied research. General surveillance guidelines are provided to assist in identifying population groups for screening, in applying descriptive epidemiology and systematic sampling, and in developing and evaluating efficient laboratory testing algorithms. Timely reporting and dissemination of data is also an important element of surveillance efforts. Ultimately, the success of global surveillance network depends on collaboration and on coordination of clinical, laboratory, and epidemiologic efforts.
Similar articles
- HIV global surveillance: foundation for retroviral discovery and assay development.
Brennan CA, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk KC, Swanson P, Yamaguchi J, Vallari A, Devare SG, Schochetman G, Hackett J Jr. Brennan CA, et al. J Med Virol. 2006;78 Suppl 1:S24-9. doi: 10.1002/jmv.20603. J Med Virol. 2006. PMID: 16622874 - The clades of HIV: their origins and clinical significance.
Stebbing J, Moyle G. Stebbing J, et al. AIDS Rev. 2003 Oct-Dec;5(4):205-13. AIDS Rev. 2003. PMID: 15011999 Review. - Molecular analyses of HIV-1 group O and HIV-2 variants from Africa.
Hunt JC, Brennan CA, Golden AM, Yamaguchi J, Lund JK, Vallari AS, Hickman RK, Zekeng L, Gürtler LG, Hampl H, Kaptué L, Devare SG. Hunt JC, et al. Leukemia. 1997 Apr;11 Suppl 3:138-41. Leukemia. 1997. PMID: 9209322 - [Diagnosis of HIV-1 non-B subtypes and HIV-2].
Toro C, Amor A, Soriano V. Toro C, et al. Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 13:66-70. doi: 10.1157/13128783. Enferm Infecc Microbiol Clin. 2008. PMID: 19100170 Review. Spanish.
Cited by
- Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation.
Shao C, Wang H, Sang F, Xu L. Shao C, et al. Drug Des Devel Ther. 2022 Aug 18;16:2731-2753. doi: 10.2147/DDDT.S369832. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36003311 Free PMC article. - A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity.
Chong H, Xue J, Xiong S, Cong Z, Ding X, Zhu Y, Liu Z, Chen T, Feng Y, He L, Guo Y, Wei Q, Zhou Y, Qin C, He Y. Chong H, et al. J Virol. 2017 May 12;91(11):e00288-17. doi: 10.1128/JVI.00288-17. Print 2017 Jun 1. J Virol. 2017. PMID: 28356533 Free PMC article. - A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Xiong S, Borrego P, Ding X, Zhu Y, Martins A, Chong H, Taveira N, He Y. Xiong S, et al. J Virol. 2016 Dec 16;91(1):e01839-16. doi: 10.1128/JVI.01839-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795437 Free PMC article. - Detection of Human Immunodeficiency Virus Type 1 (HIV-1) A/AE Circulating Recombinant Form (CRF) in India: Possible Implications.
Gupta RM, Seth P, Prasad V, Sahni AK, Jena J. Gupta RM, et al. Med J Armed Forces India. 2006 Oct;62(4):316-20. doi: 10.1016/S0377-1237(06)80095-X. Epub 2011 Jul 21. Med J Armed Forces India. 2006. PMID: 27688530 Free PMC article. - Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013.
Baesi K, Moallemi S, Farrokhi M, Alinaghi SA, Truong HM. Baesi K, et al. PLoS One. 2014 Sep 4;9(9):e105098. doi: 10.1371/journal.pone.0105098. eCollection 2014. PLoS One. 2014. PMID: 25188443 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical